WELLS FARGO & COMPANY/MN - SYROS PHARMACEUTICALS INC ownership

SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 78 filers reported holding SYROS PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 1.00 and the average weighting 0.1%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of SYROS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$0
-100.0%
361
-94.5%
0.00%
Q1 2022$8,000
-90.9%
6,621
-75.5%
0.00%
Q4 2021$88,000
+8700.0%
27,009
+18273.5%
0.00%
Q3 2021$1,0000.0%1470.0%0.00%
Q2 2021$1,000
-98.5%
147
-98.4%
0.00%
Q1 2021$67,000
-91.9%
8,961
-88.2%
0.00%
Q4 2020$827,000
+14.2%
76,212
-6.9%
0.00%
Q3 2020$724,000
-18.3%
81,858
-1.5%
0.00%
Q2 2020$886,000
+556.3%
83,105
+265.0%
0.00%
Q1 2020$135,000
-25.4%
22,768
-13.1%
0.00%
Q4 2019$181,000
-36.9%
26,195
-5.3%
0.00%
Q3 2019$287,000
+4.7%
27,648
-6.8%
0.00%
Q2 2019$274,000
-6.5%
29,667
-7.5%
0.00%
Q1 2019$293,000
+112.3%
32,061
+29.0%
0.00%
Q4 2018$138,000
+0.7%
24,851
+115.4%
0.00%
Q3 2018$137,000
-28.3%
11,537
-38.3%
0.00%
Q2 2018$191,000
-18.7%
18,685
+3.1%
0.00%
Q1 2018$235,000
+64.3%
18,129
+23.9%
0.00%
Q4 2017$143,000
-43.5%
14,630
-15.0%
0.00%
Q3 2017$253,000
+11.5%
17,217
+22.1%
0.00%
Q2 2017$227,000
+0.9%
14,1000.0%0.00%
Q1 2017$225,00014,1000.00%
Other shareholders
SYROS PHARMACEUTICALS INC shareholders Q3 2018
NameSharesValueWeighting ↓
Flagship Pioneering Inc. 4,806,656$58,449,00019.02%
Casdin Capital, LLC 182,141$2,215,0001.83%
Aisling Capital LLC 508,565$6,184,0001.44%
Redmile Group, LLC 948,440$11,533,0000.99%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,812,778$22,043,0000.91%
EcoR1 Capital, LLC 63,596$773,0000.25%
Eventide Asset Management 150,000$1,824,0000.12%
AWM Investment Company, Inc. 47,550$578,0000.11%
Weiss Multi-Strategy Advisers LLC 49,000$596,0000.03%
Baker Brothers Advisors 204,465$2,486,0000.02%
View complete list of SYROS PHARMACEUTICALS INC shareholders